It’s still early, but a company called Therapeutic Solutions International has officially filed for a patent on a treatment for Parkinson’s disease using stem cells.
“The patent application includes data, obtained in an animal model, showing that dendritic cells [a type of immune cell] obtained from umbilical cord blood have the potential to reduce inflammation in the brain while preserving dopamine-producing neurons. Parkinson’s disease is caused by impairment or death of this type of neuron.
The company hopes to pave the way for immunotherapy, a therapeutic strategy in which cells or other agents are used to help boost the body’s natural immune response.”
As always, this is in the very early stages of development. But any treatment for Parkinson’s is welcome.
Brought to you by smpltec.com, Technology for Seniors News.